Development and Testing of an Identity Measure for Transgender and Gender Diverse Persons

摘要 有证据表明，跨性别和性别多样性（TGD）的人在显着增加的风险 艾滋病毒和其他一些有害的健康结果，主要是由于普遍暴露于性别- 基于耻辱和歧视。这种歧视性待遇被TGD人内化为“身份非歧视”， 验证”是认同理论中一个成熟的行为机制，但尚未被广泛采用 研究TGD人群的研究人员。这项研究将开发第一个多维度的措施， TGD人的性别认同使用身份理论的既定指标（例如，身份标准，反映 评价、显著性/突出性/承诺评级）和机制（例如，身份不验证， 身份纠正响应）。该研究将分两个阶段进行，首先是开发阶段， 深入访谈是与一组有目的的抽样TGD人进行的， 年龄、HIV状态和性别认同（各N = 24名参与者）在6个月的时间内， 用六周时间分析访谈数据，并制定性别认同的初步维度 measure.六周的认知汇报访谈（n = 6）将证实新的表面效度 测量并允许对项目进行微调。这将结束开发阶段，并开始 测试阶段（N = 150），在该阶段可以建立新测量的可靠性和有效性，以及 可以对身份不核实与关键健康结果之间的关系进行测试。更深 更细致地了解TGD患者如何看待自己，他们如何相信其他人的看法， 以及这两种结构之间的差异如何与艾滋病毒相关的结果和风险相关 （包括接触艾滋病毒和接受/坚持抗逆转录病毒疗法或接触前预防/准备）可能会产生新的假设， 更好的研究问题，以及干预受艾滋病毒影响最严重的人群之一的新方法， 美方

Abstract Evidence demonstrates that transgender and gender diverse (TGD) persons are at dramatically elevated risk for HIV and a number of other detrimental health outcomes largely as a result of pervasive exposure to gender- based stigma and discrimination. Such prejudicial treatment is internalized by TGD persons as “identity non- verification,” a well-established behavioral mechanism in Identity Theory which has yet to be broadly adopted by researchers studying TGD populations. This study would develop the first multidimensional measure of TGD persons' gender identities using Identity Theory's established metrics (e.g., identity standards, reflected appraisals, salience / prominence / commitment ratings) and mechanisms (e.g., identity non-verification, identity corrective responses). The study would occur in two stages, beginning with a Development Stage in which in-depth interviews are carried out with a purposively sampled group of TGD persons evenly split by age, HIV status, and gender identity (N = 24 participants each) over the course of six months followed by a period of six weeks to analyze the interview data and formulate initial dimensions of the gender identity measure. Six weeks of cognitive debriefing interviews (n = 6) would then confirm the face validity of the new measure and allow for fine-tuning of items. This would conclude the Development Stage and would commence the Testing Stage (N = 150), in which the reliability and validity of the new measure could be established, and a test of how identity non-verification is associated with critical health outcomes can be carried out. A deeper and more granular understanding of how TGD persons see themselves, how they believe other people see them, and how differences between these two constructs are associated with HIV-related outcomes and risks (including exposure to HIV and uptake/adherence to ART or PEP/PrEP) could generate new hypotheses, better research questions, and new methods of intervening in one of the populations most affected by HIV in the US.